TORIPALIMAB vs TOVORAFENIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TORIPALIMAB vs TOVORAFENIB: Safety Overview
| Metric | TORIPALIMAB | TOVORAFENIB |
|---|---|---|
| Total FAERS Reports | 1,344 | 201 |
| Deaths Reported | 65 | 6 |
| Death Rate | 4.8% | 3.0% |
| Hospitalizations | 823 | 18 |
| Average Patient Age | 58.0 yrs | 19.6 yrs |
| % Female Patients | 24.9% | 62.5% |
| FDA Approval Date | N/A | Apr 23, 2024 |
| Manufacturer | Coherus Oncology, Inc. | Day One Biopharmaceuticals, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Prescription |